Search details
1.
Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.
Lancet Oncol
; 21(12): e575-e588, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33271114
2.
Human Papillomavirus Type 16 L2 DNA Methylation in Exfoliated Cervical Cells From College-Age Women.
J Low Genit Tract Dis
; 20(4): 332-7, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27518844
3.
Regulatory and clinical considerations for biosimilar oncology drugs.
Lancet Oncol
; 15(13): e594-e605, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25456378
4.
The contribution of heavy metals in cigarette smoke condensate to malignant transformation of breast epithelial cells and in vivo initiation of neoplasia through induction of a PI3K-AKT-NFκB cascade.
Toxicol Appl Pharmacol
; 274(1): 168-79, 2014 Jan 01.
Article
in English
| MEDLINE | ID: mdl-24099783
5.
Collateral damage of NUDT15 deficiency in cancer provides a cancer pharmacogenetic therapeutic window with thiopurines.
bioRxiv
; 2024 Apr 11.
Article
in English
| MEDLINE | ID: mdl-38645136
6.
Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among patients with human immunodeficiency virus.
medRxiv
; 2024 Jan 17.
Article
in English
| MEDLINE | ID: mdl-38293017
7.
Potential unintended consequences of getting rigorous with scientific rigor.
Carcinogenesis
; 39(1): 26-27, 2018 01 12.
Article
in English
| MEDLINE | ID: mdl-29045573
8.
Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
Carcinogenesis
; 34(2): 277-86, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23129580
9.
SMUG1 but not UNG DNA glycosylase contributes to the cellular response to recovery from 5-fluorouracil induced replication stress.
Mutat Res
; 743-744: 26-32, 2013.
Article
in English
| MEDLINE | ID: mdl-23253900
10.
Structural Basis for Variations in Polo-like Kinase 1 Conformation and Intracellular Stability Induced by ATP-Competitive and Novel Noncompetitive Abbapolin Inhibitors.
ACS Chem Biol
; 18(7): 1642-1652, 2023 07 21.
Article
in English
| MEDLINE | ID: mdl-37433100
11.
Inhibitors of the PLK1 polo-box domain: drug design strategies and therapeutic opportunities in cancer.
Expert Opin Drug Discov
; 18(1): 65-81, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36524399
12.
Suppression of HIV and cocaine-induced neurotoxicity and inflammation by cell penetrable itaconate esters.
bioRxiv
; 2023 Sep 26.
Article
in English
| MEDLINE | ID: mdl-37808776
13.
Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity.
Int J Cancer
; 130(7): 1660-70, 2012 Apr 01.
Article
in English
| MEDLINE | ID: mdl-21544805
14.
Quinacrine-mediated autophagy and apoptosis in colon cancer cells is through a p53- and p21-dependent mechanism.
Oncol Res
; 20(2-3): 81-91, 2012.
Article
in English
| MEDLINE | ID: mdl-23193914
15.
Human Papillomavirus Type 16 L2 DNA Methylation in Exfoliated Cervical Cells From College-Age Women: Erratum.
J Low Genit Tract Dis
; 21(2): 162, 2017 04.
Article
in English
| MEDLINE | ID: mdl-28548641
16.
Structure-activity and mechanistic studies of non-peptidic inhibitors of the PLK1 polo box domain identified through REPLACE.
Eur J Med Chem
; 227: 113926, 2022 Jan 05.
Article
in English
| MEDLINE | ID: mdl-34735919
17.
Cis- and trans-resveratrol have opposite effects on histone serine-ADP-ribosylation and tyrosine induced neurodegeneration.
Nat Commun
; 13(1): 3244, 2022 06 10.
Article
in English
| MEDLINE | ID: mdl-35688816
18.
Nonpeptidic, Polo-Box Domain-Targeted Inhibitors of PLK1 Block Kinase Activity, Induce Its Degradation and Target-Resistant Cells.
J Med Chem
; 64(14): 9916-9925, 2021 07 22.
Article
in English
| MEDLINE | ID: mdl-34210138
19.
Cation exchange on the surface of gold nanorods with a polymerizable surfactant: polymerization, stability, and toxicity evaluation.
Langmuir
; 26(12): 9328-33, 2010 Jun 15.
Article
in English
| MEDLINE | ID: mdl-20356032
20.
Peptidomimetic Polo-Box-Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor.
ChemMedChem
; 15(12): 1058-1066, 2020 06 17.
Article
in English
| MEDLINE | ID: mdl-32232973